Astellas Pharma’s logo is pictured at its headquarters in Tokyo FILE PHOTO: Astellas Pharma’s logo is pictured at its headquarters in Tokyo, Japan, December 3, 2019. REUTERS/Kim Kyung-Hoon Post navigation Previous: Japan’s Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments
